Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Medroxyprogesterone Acetate in Rat Endometrial Hyperplasia
NCT02872818Phase 4Completed
- Sponsor
- Kayseri Education and Research Hospital
- Start
- Oct 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metformin in endometrial hyperplasia (EH) (3 arms), sponsored by Kayseri Education and Research Hospital. Primary endpoints: Survivin Gene Expression Levels in Rat Uterine Tissue at 4 months, Bcl-2 Gene Expression Levels in Rat Uterine Tissue at 4 months and 3 more. Started Oct 2014; status: completed.
02
Drugs
metformin
03
Conditions
endometrial hyperplasia (EH)
Beyond the preview
Go deeper on NCT02872818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872818.